MarketCap
Facebook
X
TelegramProgenity, Inc. ROA | PROG
ROA Jährlich Progenity, Inc.
| 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 |
|---|---|---|---|---|---|---|---|---|---|
| -124.66 | - | - | - | - | - | - | - | - | - |
Jährliche Entwicklung
Kennzahlen zur Anzeige auswählen
Alle Zahlen in USD-Währung
Indikatorenreichweite aus Jahresberichten
| Höchstwert | Mindestwert | Durchschnitt |
|---|---|---|
| -124.66 | -124.66 | -124.66 |
ROA anderer Aktien in der Pharmaeinzelhändler
| Name | ROA | Preis | % 24h | Marktkapitalisierung | Land | |
|---|---|---|---|---|---|---|
 |
Aprea Therapeutics
APRE
|
-79.08 | $ 0.44 | -1.46 % | $ 2.88 M |  USA |
 |
Galectin Therapeutics
GALT
|
-157.87 | $ 3.29 | -2.66 % | $ 210 M | USA |
 |
Corcept Therapeutics Incorporated
CORT
|
11.91 | $ 74.57 | 1.66 % | $ 7.74 B | USA |
 |
Genprex
GNPX
|
-159.75 | $ 2.29 | 9.57 % | $ 2.14 M | USA |
 |
Strongbridge Biopharma plc
SBBP
|
-37.22 | - | 1.52 % | $ 136 M | USA |
 |
Innate Pharma S.A.
IPHA
|
-78.41 | $ 1.59 | 3.25 % | $ 142 M |  France |
 |
Seneca Biopharma, Inc.
SNCA
|
-124.66 | - | -1.19 % | $ 28.7 M | USA |
 |
BioMarin Pharmaceutical
BMRN
|
4.59 | $ 58.33 | 2.1 % | $ 11.2 B | USA |
 |
Matinas BioPharma Holdings
MTNB
|
-143.52 | $ 0.88 | -29.93 % | $ 4.82 M | USA |
 |
Enanta Pharmaceuticals
ENTA
|
-29.17 | $ 11.61 | 3.46 % | $ 248 K | USA |
 |
Milestone Pharmaceuticals
MIST
|
-0.06 | $ 0.68 | 2.4 % | $ 72.2 M |  Canada |
 |
Kiniksa Pharmaceuticals, Ltd.
KNSA
|
7.73 | $ 95.42 | 0.42 % | $ 7.08 B | USA |
 |
Lipocine
LPCN
|
-56.63 | $ 1.59 | -0.31 % | $ 8.66 M | USA |
 |
PTC Therapeutics
PTCT
|
23.56 | $ 64.91 | 1.2 % | $ 5.16 B | USA |
 |
Seres Therapeutics
MCRB
|
4.12 | $ 1.51 | -3.21 % | $ 13.4 M | USA |
 |
Madrigal Pharmaceuticals
MDGL
|
-22.89 | $ 432.77 | 0.04 % | $ 9.71 B | USA |
 |
CEL-SCI Corporation
CVM
|
-90.25 | $ 1.31 | -7.09 % | $ 10.5 M | USA |
 |
Inventiva S.A.
IVA
|
-154.84 | $ 4.01 | 1.65 % | $ 240 M | France |
 |
MeiraGTx Holdings plc
MGTX
|
-46.72 | $ 9.68 | 0.57 % | $ 779 M | USA |
 |
Processa Pharmaceuticals
PCSA
|
-173.59 | $ 1.85 | -1.07 % | $ 2.42 M | USA |
 |
Eton Pharmaceuticals
ETON
|
-4.99 | $ 68.4 | 1.27 % | $ 1.84 B | USA |
 |
IDEAYA Biosciences
IDYA
|
-10.25 | $ 32.71 | 3.02 % | $ 2.89 B | USA |
 |
Protalix BioTherapeutics
PLX
|
-8.02 | $ 3.13 | 9.44 % | $ 246 M |  Israel |
 |
Lantern Pharma
LTRN
|
-155.13 | $ 0.47 | 1.53 % | $ 5.12 M | USA |
 |
Foghorn Therapeutics
FHTX
|
-37.5 | $ 2.04 | 7.37 % | $ 128 M | USA |
 |
Ocugen
OCGN
|
-156.26 | $ 0.96 | 0.8 % | $ 300 M | USA |
 |
Oncolytics Biotech
ONCY
|
-157.08 | $ 0.42 | 9.19 % | $ 40.3 M | Canada |
 |
Minerva Neurosciences
NERV
|
-299.51 | $ 2.56 | 2.81 % | $ 21.7 M | USA |
 |
Kamada Ltd.
KMDA
|
5.33 | $ 8.1 | 0.43 % | $ 467 M | Israel |
 |
Neurocrine Biosciences
NBIX
|
10.33 | $ 173.86 | 2.79 % | $ 17.3 B | USA |
 |
Nanobiotix S.A.
NBTX
|
-35.36 | $ 32.73 | 0.03 % | $ 1.57 T | France |
 |
Mereo BioPharma Group plc
MREO
|
-259.95 | $ 0.31 | 2.89 % | $ 247 M |  Britain |
 |
Maravai LifeSciences Holdings
MRVI
|
-16.97 | $ 7.71 | -1.91 % | $ 1.11 B | USA |
 |
Lexicon Pharmaceuticals
LXRX
|
-27.21 | $ 1.86 | 1.34 % | $ 675 M | USA |
 |
Moleculin Biotech
MBRX
|
-151.68 | $ 8.05 | -0.12 % | $ 9.54 M | USA |
 |
Nurix Therapeutics
NRIX
|
-38.43 | $ 16.46 | 3.65 % | $ 1.43 B | USA |
 |
Nkarta
NKTX
|
-25.75 | $ 1.49 | 10.0 % | $ 110 M | USA |
 |
MacroGenics
MGNX
|
-0.03 | $ 2.33 | -3.85 % | $ 147 M | USA |
 |
Protagonist Therapeutics
PTGX
|
-19.48 | $ 134.78 | -1.06 % | $ 8.57 B | USA |
|
Nuvation Bio
NUVB
|
-34.4 | $ 4.3 | 2.26 % | $ 1.47 B | USA |
 |
Novo Nordisk A/S
NVO
|
18.87 | $ 41.06 | 0.88 % | $ 182 B |  Danmark |
 |
Marker Therapeutics
MRKR
|
-63.78 | $ 0.95 | 0.07 % | $ 14.5 M | USA |
 |
NextCure
NXTC
|
-65.84 | $ 6.3 | 5.35 % | $ 33.5 M | USA |
 |
Rocket Pharmaceuticals
RCKT
|
-67.52 | $ 2.47 | 0.82 % | $ 274 M | USA |
 |
PMV Pharmaceuticals
PMVP
|
-66.7 | $ 1.25 | 2.87 % | $ 65.7 M | USA |
 |
Olema Pharmaceuticals
OLMA
|
-30.45 | $ 8.16 | 12.24 % | $ 710 M | USA |
 |
Kymera Therapeutics
KYMR
|
17.86 | $ 135.02 | -1.19 % | $ 11.4 B | USA |
 |
Oragenics
OGEN
|
-9.78 | $ 0.35 | 1.4 % | $ 755 K | USA |
 |
Ovid Therapeutics
OVID
|
-11.53 | $ 2.77 | -1.07 % | $ 361 M | USA |